We invite you to join a free webinar titled “European Innovation Pathways in Health: Opportunities for MedTech and Biotech Companies,” dedicated to growth and funding opportunities for companies operating in the medical technology and biotechnology sectors.

Glioblastoma is one of the most formidable challenges in modern oncology—a cancer that often evades both conventional treatments and advanced immunotherapies. In the SelCell project, scientists at the Łukasiewicz – PORT are exploring a new strategy based on gamma-delta T lymphocytes. Their goal is to understand why immune cells from some donors can destroy tumor cells far more effectively than those from others.

The WABIO Project has secured over PLN 7 million under the TEAM NET program to develop and validate an integrated biorefinery prototype within the consortium. The work at Łukasiewicz will be led by Prof. Andrzej Białowiec.

On February 24, at the headquarters of the Foundation for Polish Science, we officially launched the implementation of the International Research Agendas (MAB) project within the P4Health Center of Excellence.

February 19 marks Polish Science Day –established on the anniversary of Nicolaus Copernicus’s birth and honoring the achievements of successive generations of researchers. At Łukasiewicz – PORT, we view Polish science within a broad international context.

Thanks to this funding, Dr. Rohit Shrivastava will carry out the AstroExo-HD project, whose aim is to develop new methods for early diagnosis and to identify potential therapeutic targets in Huntington’s disease.

Impairment of blood–brain barrier (BBB) function is among the earliest indicators of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and vascular dementia. During the seminar, Dr. Mootaz Salman will discuss how inflammation-mediated BBB dysfunction disrupts cerebrovascular integrity and how research aims to prevent irreversible neurodegenerative changes.

“I follow wherever the data lead me,” says Dr. Vitor Cabral, who has spent years building his scientific expertise across disciplines and continents – from classical microbiology and genetics, through infection biology, to synthetic biology and translational research. Today, at Łukasiewicz – PORT, he draws on this interdisciplinary background to design microbiome-based therapeutic strategies.

The year 2025 marked a period of step-change growth in the research capacity of Łukasiewicz – PORT. Newly acquired, highly specialized infrastructure represents not only a modernization of facilities, but also the opening of new research directions in the fight against brain tumors, chronic pain, and the energy crisis.

On January 28, 2026, at Łukasiewicz – PORT in Wrocław, a funding agreement was signed for the winning project of the fourth Virtual Research Institute competition, marking the launch of the PACMAN oncology research project.